Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on OncoSil Medical.
RELATED STOCKHEAD STORIES
News
Market Highlights: AI stocks up as Google unveils ChatGPT’s rival Gemini, and 5 ASX small caps to watch
News
Market Highlights: Dovish comments from Fed, gold nears all-time high, and 5 ASX small caps to watch
News
In Case You Missed It: High grade gold for the win
Health & Biotech
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads
Health & Biotech
ASX Health Stocks: OncoSil to commence trial; Korea and Malaysia next stops for these biotechs
Health & Biotech
ASX Health Stocks: Clarity reveals Phase 1 success; Starpharma and Oncosil head for Asia
Health & Biotech
ASX Health Stocks: HeraMED up 17pc and Mesoblast 12pc after strong study results
Health & Biotech
ASX Health Stocks: HitIQ and Volpara prove world class technology after signing major US deals
News
Top 10 at 10: These ASX stocks are out front in a flash
News
Closing Bell: Welcome to the palladium and uranium show
Health & Biotech
Who’s carrying on the Cochlear legacy? The ASX med device stocks that could soar from tailwinds
Health & Biotech
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Small caps go full Maximus, unleash gains in face of rising broad-based fears
News
ASX Small Cap Lunch Wrap: Who’s standing to attention today?
News
ASX Health Stocks: OncoSil rips higher as its device goes live in Spain
News
